Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 449
Titolo Data di pubblicazione Autore(i) File
INTERMEDIATE-DOSE CYCLOPHOSPHAMIDE FOLLOWED BY INTERFERON-ALPHA-2B AND PREDNISONE MAINTENANCE THERAPY FOR REFRACTORY MYELOMA 1994 PALUMBO A; BOCCADORO M; TRIOLO S; BRUNO B; FRIERI R; MAIRONE L; RAVIOLO E; LURASCHI A; INFELISE V; DARBESIO A; PILERI A
Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis. 1994 ATTISANO N; BIANCHI A; MONTACCHINI L; CARLESSO N; PEOLA S; BRUNO B; ROUX V; FERRERO D; GALLO E; BOCCADORO M; PILERI A; M. MASSAIA
Recombinant interferon-gamma in a patient with multiple myeloma. 1994 Palumbo A; Bruno B; Triolo S; Boccadoro M; Pileri A
INTENSIFIED TREATMENT WITH CIRCULATING PROGENITOR-CELL (CPC) SUPPORT IN MULTIPLE-MYELOMA - SEQUENTIAL CYCLOPHOSPHAMIDE MELPHALAN 1994 BOCCADORO M; PALUMBO A; BRUNO B; TRIOLO S; OMEDE P; SORMANO E; CAPALDI A; PILERI, A
Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma. 1994 Palumbo A; Boccadoro M; Triolo S; Bruno B; Pileri A
Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma. 1994 PALUMBO A ;BOCCADORO M ;BRUNO B ;TRIOLO S ;PILERI A
kappa/lambda ratio: a valid tool in the monitoring of multiple myeloma 1995 Battaglio S; Napoli P; Bruno B; Boccadoro M
Sequential cyclophosphamide-melphalan (CM) with circulating progenitor cell (CPC) support in multiple myeloma 1995 Boccadoro M; Palumbo A; Bruno B; Triolo S; Omede P; Argentino C; Pileri A
Interferon-gamma in multiple myeloma. 1995 PALUMBO A; B. BRUNO; BOCCADORO M; PILERI A
Retinoic acid inhibits the growth of human myeloma cells in vitro. 1995 Palumbo A; Battaglio S; Napoli P; Bruno B; Omedè P; Boccadoro M; Pileri A
REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAL BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTLY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM) 1996 LADETTO M; SAMETTI POS; DONOVAN JW; ASTOLFI M; GIACCONE L; GIARETTA F; VOPATA F; BRINGHEN S; PALUMBO A; BRUNO B; PILERI A; GRIBBEN JG; BOCCADORO M
Adenovirus nephritis: A newly described clinical-pathological entity in bone marrow transplantation. 1996 Bruno B; Boeckh M; Zager D; Hackman RC
Evaluation of a panel of monoclonal antibodies (MAB) that recognize canine CD34. 1996 McSweeney PA; Rouleau KA; Nash RA; Bolles L; KrizanacBengez L; Andrews R; Woodger P; Bruno B; Wayner E; Storb R; Wallace PM
Combined differentiating therapy for myelodysplastic syndromes: a phase II study. 1996 FERRERO D; B. BRUNO; PREGNO P; STEFANI S; LARIZZA E; CIRAVEGNA G; LURASCHI A; VIETTI-RAMUS G; SCHINCO P; BAZZAN M; GALLO E; PILERI A
Significantly improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells and a gibbon APE leukemia virus (GALV) pseudotyped retroviral vector. 1997 Kiem HP; McSweeney P; Heyward S; Bruno B; Buron G; Storb R; Miller AD
A method for immunomagnetic separation of CD34+ canine hematopoietic progenitors for stem cell transplantation. 1997 Bruno B; Wallace PM; Nash RA; Andrews RG; Storb R; McSweeney PA
Multicyclic, dose-intensive chemotherapy supported by hemopoietic progenitors in refractory myeloma patients. 1997 Palumbo A; Pileri A; Triolo S; Omedè P; Bruno B; Ciravegna G; Galliano M; Frieri R; Boccadoro M
Adenovirus infections in patients undergoing bone marrow transplantation. 1997 Bruno B; Boeckh M; Davis C; Gooley T; Hackman RC
Secondary failure of platelet recovery in hematopoietic stem cell transplantation (HSCT). 1998 Bruno B; Gooley T; Sullivan K; Davis C; Bensinger WI; Storb R; Nash RA
Characterization of monoclonal antibodies that recognize canine CD34. 1998 MCSWEENEY PA; ROULEAU KA; WALLACE PM; B. BRUNO; ANDREWS RG; KRIZANAC-BENGEZ L; SANDMAIER BM; STORB R; WAYNER E; NASH RA
Mostrati risultati da 1 a 20 di 449
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile